156 related articles for article (PubMed ID: 23163293)
21. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
22. [Infectious markers among blood donors in Democratic Republic of Congo (DRC)].
Batina A; Kabemba S; Malengela R
Rev Med Brux; 2007; 28(3):145-9. PubMed ID: 17708468
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
[TBL] [Abstract][Full Text] [Related]
24. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
25. The incidence of hepatitis C in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study.
Azarkeivan A; Toosi MN; Maghsudlu M; Kafiabad SA; Hajibeigi B; Hadizadeh M
Transfusion; 2012 Aug; 52(8):1814-8. PubMed ID: 22500658
[TBL] [Abstract][Full Text] [Related]
26. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
27. Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope.
Ismail AM; Ziada HN; Sheashaa HA; Shehab El-Din AB
Eur J Intern Med; 2009 Sep; 20(5):490-3. PubMed ID: 19712851
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients.
Mansour AK; Aly RM; Abdelrazek SY; Elghannam DM; Abdelaziz SM; Shahine DA; Elmenshawy NM; Darwish AM
Hematol Oncol Stem Cell Ther; 2012; 5(1):54-9. PubMed ID: 22446611
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
31. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
Zawde D; Sisay Y
Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
[TBL] [Abstract][Full Text] [Related]
32. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
[TBL] [Abstract][Full Text] [Related]
33. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study.
Zou S; Notari EP; Stramer SL; Wahab F; Musavi F; Dodd RY;
Transfusion; 2004 Nov; 44(11):1640-7. PubMed ID: 15504171
[TBL] [Abstract][Full Text] [Related]
34. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
35. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
36. Demographics of apheresis platelet donors in five blood centers in China.
Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
[TBL] [Abstract][Full Text] [Related]
37. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
38. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
Wang JE
J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
[TBL] [Abstract][Full Text] [Related]
39. [Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital].
Aydin F; Cubukçu K; Yetişkul S; Yazici Y; Kaklikkaya N
Mikrobiyol Bul; 2002 Jan; 36(1):85-90. PubMed ID: 12476771
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
Chandra T; Kumar A; Gupta A
Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
